Oxford vaccine offers hope, trials in India soon

The first set of results from early-stage clinical trials of the Oxford University Covid-19 vaccine candidate show the vaccine is safe and induces an immune reaction, according to results published in the Lancet, a medical journal, on Monday. The results from Oxford were followed by Indian vaccine manufacturer Serum Institute announcing it would seek regulatory approvals for clinical trials in India.